Swelling losses haven't held back gains for Inovio Pharmaceuticals (NASDAQ:INO) shareholders since they're up 56% over 3 years

Simply Wall St
·2 min read

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shareholders might be concerned after seeing the share price drop 20% in the last week. In contrast the stock is up over the last three years. Arguably you'd have been better off buying an index fund, because the gain of 56% in three years isn't amazing.

While this past week has detracted from the company's three-year return, let's look at the recent trends of the underlying business and see if the gains have been in alignment.

Check out our latest analysis for Inovio Pharmaceuticals

Because Inovio Pharmaceuticals made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.

Inovio Pharmaceuticals actually saw its revenue drop by 83% per year over three years. The revenue growth might be lacking but the share price has gained 16% each year in that time. Unless the company is going to make profits soon, we would be pretty cautious about it.

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

earnings-and-revenue-growth
earnings-and-revenue-growth

Take a more thorough look at Inovio Pharmaceuticals' financial health with this free report on its balance sheet.

A Different Perspective

While the broader market gained around 32% in the last year, Inovio Pharmaceuticals shareholders lost 48%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 2% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for Inovio Pharmaceuticals you should know about.

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting

Recommended Stories

  • 5 Popular Stocks Billionaires Couldn't Sell Fast Enough in the Second Quarter

    This was when institutional investment firms and hedge funds with at least $100 million in assets under management were required to file Form 13F with the Securities and Exchange Commission (SEC). Put simply, a 13F provides a snapshot of what institutional investors and hedge fund managers have been buying and selling over the previous quarter (in this instance, 4/1 through 6/30). Although anything having to do with alternative-power vehicles has seemingly been red-hot for years, billionaires headed for the exit in the second quarter when it came to hydrogen fuel-cell solutions provider Plug Power (NASDAQ: PLUG).

  • Billionaire John Paulson Goes Big on These 2 High-Yield Dividend Stocks

    Every retail investor wants to ensure a solid portfolio return. The only question is, how? The stock market produces a vast mine of data, that by its nature forms a barrier to access. Some investors take a path of low resistance, and follow one or more market legends. These legends are the giants of the investing world, people like John Paulson. Paulson got his start in hedge management in 1994 with $2 million worth of initial capital. He was successful, and by 2003 he was managing $300 million

  • Why AT&T's Spinoff Could Benefit Long-Term Investors

    AT&T (NYSE: T) is breaking up into three companies, which could unlock significant value for shareholders. How is AT&T splitting up? AT&T: A telecom company solely focused on 5G communications and broadband.

  • 4 Stocks Billionaires Bought Hand Over Fist in the Second Quarter

    Earlier this week marked the deadline for institutional investment firms, hedge funds, and the ultra-rich to file Form 13F with the Securities and Exchange Commission (SEC). Although it's a dated snapshot that can be at least six weeks old at the time of the SEC filing, it still provides insight into the stocks and trends billionaire money managers might be chasing or shying away from. After poring over 13F data from aggregator WhaleWisdom.com, it became plainly evident that growth stocks were still very much on the minds of billionaire money managers.

  • MLB, Players Ending Topps Card Deal for Fanatics Joint Venture

    Major League Baseball and the MLB Players Association are set to make a massive lineup change—ending an 70-year partnership with Topps to work with Fanatics on licensed trading cards starting in 2026. Topps has been producing baseball cards since 1951, and received an exclusive license from MLB in 2009. That agreement was later extended through […]

  • The S&P 500 hasn’t fallen by at least 5% in nearly 200 sessions — Here’s what history says happens next

    Absent a sharp sell off, Friday will mark the 200th session that the S&P 500 index hasn't produced a drawdown of at least 5% from its recent peak, making the current stretch of equity levitation the longest since 2016, when the market went 404 sessions without falling by at least 5% peak to trough.

  • Ark’s Cathie Wood says stock market ‘couldn’t be further away from a bubble.’ Here’s why.

    Star investor Cathie Wood, who runs a suite of popular ETFs in Ark Investment Management, says that there's no reason to fear that the market is becoming too bubblicious.

  • Thailand CBDC Trial to Test Use as Cash Substitute

    The CBDC will be used for "cash-like activities within a limited scale," such as paying for goods and services.

  • Zambia Election Euphoria Fuels Kwacha’s World-Beating Streak

    (Bloomberg) -- Zambia’s kwacha extended its gains versus the dollar, making it the world’s best-performing currency since Hakainde Hichilema was announced the winner of the Aug. 12 presidential vote. The kwacha has appreciated by 7.8% this week to 17.92 per dollar, the best performance out of more than 140 currencies tracked by Bloomberg globally and on track for the strongest close since May 2020. The southern African nation’s $1 billion Eurobonds due 2024 advanced for a fourth straight day to

  • 10 Best Stocks to Buy According to Michael Burry

    In this article, we discuss the 10 best stocks to buy according to Michael Burry. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Stocks to Buy According to Michael Burry. Michael Burry, the chief of California-based Scion Asset Management, manages more than $2 billion in assets […]

  • 10 Best Stocks to Buy According to Warren Buffett

    In this article, we discuss the 10 best stocks to buy according to Warren Buffett. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Stocks to Buy According to Warren Buffett. Warren Buffett, the chief of Nebraska-based Berkshire Hathaway, is one of the most successful investors in […]

  • Do Options Traders Know Something About Plug Power (PLUG) Stock We Don't?

    Investors need to pay close attention to Plug Power (PLUG) stock based on the movements in the options market lately.

  • The Stock Market Is Dropping Again. What’s Behind Its Worst Slump Since July.

    S&P 500 futures have declined 0.6% Thursday morning, indicating an opening loss of around 28 points, or 0.6%, for the index. If the losses hold, it would be the S&P 500’s third consecutive drop, the index’s longest losing streak since the three-day losing streak that ended on July 19.

  • 2 Growth Stocks With 83% to 116% Upside, According to Wall Street

    Famed investor Benjamin Graham once made an interesting observation: "In the short term, the market is a voting machine; but in the long run, it is a weighing machine." Put another way, a stock's price on any given day is heavily influenced by its popularity, but the underlying fundamentals ultimately matter more over time.

  • ‘The Next Amazon’: 10 Undervalued Ecommerce Stocks with Huge Upside

    In this article, we discuss the 10 undervalued ecommerce stocks with huge upside. If you want to skip our detailed analysis of these stocks, go directly to ‘The Next Amazon’: 5 Undervalued Ecommerce Stocks with Huge Upside. The ecommerce business has become one of the main drivers of the world economy in recent years. According […]

  • Nvidia’s ARM acquisition is stalled, and there’s a deadline with more than a billion dollars at stake

    Nvidia has another year to complete its proposed $40 billion acquisition of chip designer ARM Holdings before it faces any kind of financial ramifications if the deal does not get done.

  • 3 Shockingly Cheap Dividend Stocks

    Values can be hard to find on the stock market, especially after the rally we've had since early 2020. Procter & Gamble was a strong business before the pandemic struck, and it has only boosted its value since then.

  • Options Trader Takes Massive Position In Virgin Galactic Stock: Where Is It Headed?

    On Aug. 12, Sir Richard Branson’s Virgin Investments dumped $300 million worth of Virgin Galactic Holdings, Inc (NYSE: SPCE) stock. The billionaire said the proceeds from the sale would go toward helping his other businesses recover from the COVID-19 pandemic. The day prior to Branson selling 10,416,000 shares of his space tourism company, Morgan Stanley analyst Kristine Liwag downgraded the stock from Equal-weight to Underweight and gave a $25 price target. Although Unity23 is expected to fly t

  • World’s Three Largest Auto Makers Face New Production Cuts. Other Stocks Are Falling.

    Shares of Toyota Motor, Volkswagen, and Ford Motor tumbled Thursday amid reports that the global semiconductor shortage has created new bottlenecks.

  • The Fed Tapering Has Already Begun

    The growth rate of the Federal Reserve's balance sheet has fallen to 11% year over year from 80% at the height of the pandemic last year.